Study guide

13.4 Accreditation Standards & Outcomes of APRN Practice

Advanced Oncology Certified Nurse Practitioner AOCNP

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the AOCNP Exam 1.2 How to Use This AOCNP Study Guide

2 Chapter 2: Cancer Continuum - Risk, Prevention & Screening

2.1 Cancer Risk Factors, At-Risk Populations & Health Disparities 2.2 Primary Prevention, Vaccination, Chemoprevention & Risk-Reducing Surgery 2.3 Cancer Screening & Early Detection Guidelines 2.4 Screening for Subsequent & Second Primary Malignancies 2.5 Hereditary Cancer Syndromes & Genetic Counseling

3 Chapter 3: Cancer Continuum - Assessment, Diagnosis & Staging

3.1 Diagnostic Workup, Tissue Biopsy & Biomarker Evaluation 3.2 Pathology Interpretation, Histology & Tumor Grading 3.3 Cancer Staging Systems (TNM) & Prognostication Models 3.4 Performance Status, Frailty & Geriatric Assessment

4 Chapter 4: Cancer Continuum - Planning, Coordination & Survivorship

4.1 Established Guidelines for Care & Categories of Evidence 4.2 Individualized Treatment Planning & Molecular Tumor Boards 4.3 Reproductive Planning & Fertility Preservation 4.4 Patient Navigation & Interprofessional Care Coordination 4.5 Survivorship Care Planning & Late Effects Management 4.6 Post-Treatment Surveillance for Cancer Recurrence

5 Chapter 5: Cancer Treatment - Antineoplastic Pharmacology & Chemotherapy

5.1 Antineoplastic Principles, Dosing & Dose Adjustments 5.2 Cytotoxic Chemotherapy Classes & Adverse Effect Management 5.3 Safe Administration, Handling & Infusion Toxicities 5.4 Oral Antineoplastic Therapy: Adherence, Interactions & Monitoring

6 Chapter 6: Cancer Treatment - Targeted, Immuno & Hormonal Therapies

6.1 Targeted Therapies, Tyrosine Kinase Inhibitors & ADCs 6.2 Cancer Immunotherapy, Checkpoint Inhibitors & CAR T-Cell Therapy 6.3 Endocrine & Hormonal Therapies in Oncology

7 Chapter 7: Cancer Treatment - Radiation, Surgery, Regional & Multimodal Therapy

7.1 Radiation Oncology Principles & Toxicity Management 7.2 Surgical Oncology, Perioperative Care & Reconstruction 7.3 Regional & Localized Therapy Administration 7.4 Multimodal Therapy & Treatment Sequencing 7.5 Complementary, Alternative & Integrative Therapies

8 Chapter 8: Cancer Treatment - Transplantation, Clinical Trials & Response

8.1 Hematopoietic Stem Cell Transplantation (HSCT) & Cell Therapy 8.2 Clinical Trials, Research Protocols & Response Evaluation (RECIST)

9 Chapter 9: Supportive Care - Pain & Controlled Substance Safety

9.1 Cancer Pain Assessment & Comprehensive Analgesic Management 9.2 Controlled Substance Safety & Opioid Stewardship 9.3 Nonpharmacologic & Integrative Symptom Interventions

10 Chapter 10: Supportive Care - Symptom & Comorbidity Management

10.1 Acute, Late & Long-Term Patterns of Treatment-Related Symptoms 10.2 Gastrointestinal Symptom Management (CINV, Mucositis, Diarrhea) 10.3 Hematologic & Neurologic Toxicity Management 10.4 Dermatologic, Metabolic & Fatigue Management 10.5 Cancer-Associated Thrombosis & Anticoagulation 10.6 Comorbid Conditions & Their Interaction With Cancer Treatment 10.7 Palliative Care, Hospice & End-of-Life Management

11 Chapter 11: Oncologic Emergencies

11.1 Superior Vena Cava Syndrome & Structural Emergencies 11.2 Spinal Cord Compression & Neurologic Emergencies 11.3 Metabolic Emergencies: Tumor Lysis Syndrome & Hypercalcemia of Malignancy 11.4 Febrile Neutropenia, Sepsis & Vesicant Extravasation 11.5 Cardiopulmonary & Airway Emergencies 11.6 Hematologic & Endocrine Emergencies: DIC, Leukostasis, Hyperviscosity & SIADH

12 Chapter 12: Psychosocial Issues

12.1 Psychosocial Assessment & Distress Screening in Oncology 12.2 Risk Factors & At-Risk Oncology Populations 12.3 Psychosocial & Emotional Sequelae of Disease and Treatment 12.4 Psychiatric & Psychosocial Comorbidities in Cancer Care 12.5 Caregiver Burden, Support & Community Resources

13 Chapter 13: Professional Practice & Roles of the APRN

13.1 APRN Scope of Practice, Prescriptive Authority & Standards of Care 13.2 Bioethics, Informed Consent & Quality Improvement in Oncology 13.3 Cultural Competence, Implicit Bias & Equitable Oncology Care 13.4 Accreditation Standards & Outcomes of APRN Practice 13.5 Competency Evaluation, Peer Review & Peer Education

13.4 Accreditation Standards & Outcomes of APRN Practice

Key Takeaways Explain This Topic AI

Commission on Cancer accreditation requires a cancer committee, an annual cancer registry, multidisciplinary conferences, guideline-concordant care, psychosocial distress screening, survivorship services, and palliative care access.

NCI designation is a research designation with three tiers, and Comprehensive status requires depth and breadth across basic, clinical, and population science plus community outreach and engagement.

FACT accreditation applies specifically to hematopoietic cell therapy and immune effector cell programs and governs collection, processing, and clinical care standards.

Donabedian's framework classifies quality measures as structure, process, or outcome, and process measures dominate oncology quality programs because outcomes require long follow-up and heavy risk adjustment.

APRN-sensitive outcomes include time to treatment initiation, symptom management response, unplanned emergency department visits and admissions, advance care planning documentation, distress screening completion, and trial enrollment rates.

Last updated: August 2026

13.4 Accreditation Standards & Outcomes of APRN Practice

Blueprint focus: ONCC Domain V.C ( accreditation standards, e.g. Commission on Cancer, National Cancer Institute, FACT ), V.F ( outcomes of APRN interventions and evidence-based care on individuals, groups, and systems ), and V.G ( quality improvement strategies ).

The Accreditation Landscape

Body What it accredits Core requirements the APRN encounters

Commission on Cancer (CoC) , a program of the American College of Surgeons Cancer programs — hospitals and cancer centers Multidisciplinary cancer committee; a maintained cancer registry with annual reporting and follow-up; regular multidisciplinary case conferences; guideline-concordant treatment; psychosocial distress screening ; survivorship program services; palliative care access; clinical trial accrual; annual quality studies

National Cancer Institute (NCI) Research capacity at cancer centers Three tiers: Basic Laboratory , Cancer Center , and Comprehensive Cancer Center . Comprehensive status requires depth and breadth across basic, clinical, and population sciences plus community outreach and engagement and demonstrated transdisciplinary collaboration. NCI designation is about research infrastructure, not about clinical accreditation of care delivery

FACT (Foundation for the Accreditation of Cellular Therapy) Hematopoietic cell therapy and immune effector cell programs Standards spanning clinical program, collection facility, and processing facility; personnel qualification and training; quality management; outcome reporting; CAR T-cell and other immune effector cell-specific standards

ASCO QOPI® (Quality Oncology Practice Initiative) Oncology practices Voluntary measure-based self-assessment with QOPI Certification available; measures include staging documentation before treatment, biomarker testing before targeted therapy, chemotherapy consent, pain and emesis assessment at each visit, antiemetic guideline concordance, and timely palliative care referral

ONS Nursing practice standards Chemotherapy and immunotherapy administration standards, safe handling, and competency frameworks; jointly published with ASCO for chemotherapy administration safety

The Joint Commission Hospitals and health systems National Patient Safety Goals; medication management; the Universal Protocol ; disease-specific care certification

ANCC Magnet Recognition Nursing excellence at the organization level Transformational leadership, structural empowerment, exemplary professional practice, new knowledge and innovation, and empirical outcomes — which requires nurse-sensitive outcome data

NCCN Member Institutions Guideline-developing institutions Not an accreditation program, though frequently confused with one

The distinction most often tested: CoC accredits care delivery , NCI designates research capacity , and FACT accredits cell therapy programs . A hospital can be CoC-accredited without being NCI-designated, and vice versa.

The Donabedian Framework

Quality measures fall into three categories.

Type Definition Oncology examples

Structure The setting and resources Board-certified staffing ratios, availability of an oncology pharmacist, presence of an infusion safety program, electronic health record capability

Process What is actually done Percentage of patients with stage documented before treatment, antiemetic guideline concordance, distress screening completion rate, time from diagnosis to treatment

Outcome What happens to the patient Survival, unplanned admission rate, patient-reported symptom burden, treatment-related mortality, patient experience

Most oncology quality programs are dominated by process measures , because outcomes take years to mature and require heavy risk adjustment that small practices cannot perform. Process measures are actionable and attributable; outcome measures are what patients actually care about. A good quality program uses both.

Outcomes of APRN Practice

Domain V.F asks specifically about the effect of APRN interventions at three levels.

Individual level. Symptom control, functional status, adherence, patient experience, self-management capability, and goal-concordant care.

Group and population level. Reduced time to treatment initiation, higher rates of guideline-concordant care, higher distress screening and survivorship care plan completion, higher advance care planning documentation, higher clinical trial screening and enrollment, and reduced disparities in these measures across subgroups.

System level. Reduced unplanned emergency department visits and hospital admissions, shortened length of stay, improved access and clinic throughput, cost avoidance, and improved continuity across care transitions.

Evidence base. APRN-led oncology care has repeatedly demonstrated outcomes comparable to physician-delivered care for survivorship follow-up, symptom management, and chronic disease management, with equal or higher patient satisfaction. APRN-led symptom triage and telephone or remote monitoring programs reduce avoidable emergency department utilization. Early palliative care delivered substantially by advanced practice clinicians improves quality of life, reduces depressive symptoms, and in the landmark metastatic NSCLC trial was associated with less aggressive end-of-life care and longer survival.

Measuring your own contribution is a professional obligation, not an optional exercise. Choose measures you can actually attribute: time to treatment initiation for your panel, percentage of your patients with a documented survivorship care plan, unplanned admissions among patients enrolled in your symptom-monitoring program, distress screening completion, advance care planning documentation, and trial screening rates.

Quality Improvement Methods

  • Method Nature Use
  • PDSA (Plan-Do-Study-Act) Iterative small-scale testing Rapid-cycle improvement of a defined process
  • Lean Waste elimination and flow Clinic throughput, chemotherapy turnaround, reducing waiting
  • Six Sigma (DMAIC) Variation reduction Standardizing high-variability, error-prone processes

Root cause analysis (RCA) Retrospective Investigating a sentinel event or near miss to find latent system flaws rather than individual blame

Failure mode and effects analysis (FMEA) Prospective Identifying failure points before implementing a new process, such as a new CAR T-cell pathway

RCA versus FMEA is a recurring exam item. RCA looks backward at an event that happened; FMEA looks forward at an event you are trying to prevent.

Quality improvement is not human subjects research. QI aims to improve local care using existing evidence and generally does not require IRB approval, though intent to generate generalizable knowledge and publish can move a project into research territory — when in doubt, ask the IRB rather than assume.

Value-Based Payment in Oncology

Oncology Care Model (OCM) and its successor the Enhancing Oncology Model (EOM) are CMS episode-based payment models tying payment to quality and total cost of care during a chemotherapy episode. Both require the IOM/NASEM 13-point care management plan , 24/7 access to a clinician with real-time medical record access, patient navigation, and continuous quality improvement — all of which are work the oncology APRN performs.

MIPS (Merit-based Incentive Payment System) adjusts Medicare payment based on quality, cost, improvement activities, and interoperability.

CMS Oncology Care measures include chemotherapy administered in the last 14 days of life, hospice enrollment for fewer than 3 days before death, and emergency department utilization — all measures the APRN can move directly through advance care planning and proactive symptom management.

Understanding which measures the practice is judged on tells you where APRN effort will be visible in the data, which is how quality improvement work becomes sustainable rather than voluntary.

Loading diagram... Accreditation, Quality Measurement, and APRN Outcomes